Search - tctmd.com

Displaying 521 - 540 of 1494

Sort: Relevancy | Date

For Angina Patients, Language Barriers Can Complicate CVD Care

News Daily News

For Angina Patients, Language Barriers Can Complicate CVD Care

December 20, 2021

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

News Features

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

December 16, 2021

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

December 09, 2021

Another Study Links Stopping Statins to MACE in the Elderly

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

December 03, 2021

INTERSTROKE: Anger, Heavy Physical Exertion May Trigger Strokes

News Daily News

INTERSTROKE: Anger, Heavy Physical Exertion May Trigger Strokes

December 02, 2021

Best Exercise for Heart Health? Some Hints of Intensity’s Role

News Daily News

Best Exercise for Heart Health? Some Hints of Intensity’s Role

Michael O'Riordan

December 02, 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

November 26, 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

November 18, 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

News Conference News AHA 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

Yael L. Maxwell

November 14, 2021

Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders

News Conference News AHA 2021

Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders

November 14, 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

News Conference News AHA 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Michael O'Riordan

November 13, 2021

Village-Level Intervention Nets Big BP Control Gains in Rural China

News Conference News AHA 2021

Village-Level Intervention Nets Big BP Control Gains in Rural China

November 13, 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 08, 2021

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Presentation TCT 2021

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Presenter: Daniel Burkhoff

November 05, 2021

Adequacy of Blood Pressure Control in High-Risk Hypertensive Patients: The DEGREE Study

Presentation TCT 2021

Adequacy of Blood Pressure Control in High-Risk Hypertensive Patients: The DEGREE Study

Presenter: Victor Zeijen

November 04, 2021

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Presentation TCT 2021

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Presenter: Daniel Burkhoff

November 04, 2021

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Presentation TCT 2021

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Presenter: Herbert D. Aronow

November 04, 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

November 04, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.